SARS-CoV-2 感染诱导了亲纤维和亲血栓泡细胞的形成
Diana M Battaglia1,2,3,4, Claire E Post2,3,4, Wenbo Yao2,3,4,5
1Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.
Nature microbiology
|August 22, 2025
概括
严重急性呼吸系统冠状病毒2 (SARS-CoV-2) 感染导致巨细胞和泡细胞的增加,导致肺纤维化. 抗病毒治疗防止了这些影响,这表明COVID-19并发症的治疗目标.
科学领域:
- 免疫学
- 病理学
- 病毒学
背景情况:
- COVID-19 和长期COVID涉及免疫失调,但巨细胞的作用尚不清楚.
- 巨细胞是关键的免疫细胞,但它们在SARS-CoV-2病变发生过程中的具体参与需要阐明.
研究的目的:
- 研究巨细胞在SARS-CoV-2感染和随后的肺病理中的作用.
- 为了确定SARS-CoV-2引起的巨细胞变化是否与其他冠状病毒相比具有特异性.
- 评估抗病毒治疗对COVID-19中巨相关病理的影响.
主要方法:
- 使用了人性化小鼠, rhesus macaques 和死后的人类肺组织.
- 分析了巨细胞的增殖,泡细胞的形成和基因表达特征.
- 评估了EIDD-2801 (抗病毒药物) 对感染引起的病理的影响.
主要成果:
- 在多种模型中,SARS-CoV-2 感染增加了巨细胞数量并诱导了泡细胞的形成.
- 其他测试的冠状病毒没有诱导这些巨细胞反应.
- 泡细胞表现出亲纤维和亲血栓的基因特征.
- 在病毒清除后,巨细胞和肺纤维化持续升高.
- 治疗EIDD-2801抑制了巨细胞的增殖,泡细胞的形成和纤维化标志物的减少.
结论:
- SARS-CoV-2 感染独特地推动了巨细胞的积累和泡细胞的形成,导致肺炎,纤维化和血栓形成.
- 大细胞在COVID-19相关的肺损伤中起着重要作用.
- 使用EIDD-2801的早期抗病毒干预可以缓解这些巨介导的病理过程.
更多相关视频
相关概念视频
Coronary Artery Disease II: Pathophysiology
34
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
34
Inflammation
55.1K
Overview
55.1K
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Atherosclerosis I: Introduction
77
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
77
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
46
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
46
Cystic Fibrosis: Pathogenesis
360
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
360


